Detalhe da pesquisa
1.
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
Mult Scler;
29(6): 648-656, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36440826
2.
Gut Microbiome in Progressive Multiple Sclerosis.
Ann Neurol;
89(6): 1195-1211, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33876477
3.
A probiotic modulates the microbiome and immunity in multiple sclerosis.
Ann Neurol;
83(6): 1147-1161, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29679417
4.
Investigation of probiotics in multiple sclerosis.
Mult Scler;
24(1): 58-63, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29307299
5.
Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE.
iScience;
26(11): 108143, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37915599
6.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
Mult Scler Relat Disord;
70: 104486, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36628884
7.
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding.
Nat Cell Biol;
7(7): 665-74, 2005 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15951807
8.
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
Microbiome;
10(1): 174, 2022 10 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36253847
9.
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis.
Mult Scler Relat Disord;
62: 103737, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35533419
10.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
medRxiv;
2022 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35734083
11.
Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.
Sci Rep;
9(1): 12460, 2019 08 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31462662
12.
Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila.
Cell Host Microbe;
26(6): 779-794.e8, 2019 12 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31784260
13.
SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex.
Mol Neuropsychiatry;
2(1): 20-27, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27525255
14.
Alterations of the human gut microbiome in multiple sclerosis.
Nat Commun;
7: 12015, 2016 06 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27352007
15.
Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.
Science;
339(6117): 335-9, 2013 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23329051
16.
Postsynaptic density: a key convergent site for schizophrenia susceptibility factors and possible target for drug development.
Drugs Today (Barc);
43(9): 645-54, 2007 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17940640
17.
Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.
Proc Natl Acad Sci U S A;
104(36): 14501-6, 2007 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17675407